↓ Skip to main content

Cochrane Database of Systematic Reviews

Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses

Overview of attention for article published in Cochrane database of systematic reviews, April 2005
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
7 tweeters

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
206 Mendeley
Title
Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses
Published in
Cochrane database of systematic reviews, April 2005
DOI 10.1002/14651858.cd003729.pub2
Pubmed ID
Authors

Ravindra B Belgamwar, Mark Fenton

Abstract

People presenting with agitated or violent behaviour thought to be due to severe mental illness may require urgent pharmacological tranquillisation. Several preparations of olanzapine, an antipsychotic drug, are now being used for management of such agitation.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 206 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 <1%
United Kingdom 1 <1%
Israel 1 <1%
Canada 1 <1%
Netherlands 1 <1%
Unknown 200 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 34 17%
Researcher 33 16%
Student > Bachelor 29 14%
Student > Ph. D. Student 21 10%
Other 20 10%
Other 42 20%
Unknown 27 13%
Readers by discipline Count As %
Medicine and Dentistry 79 38%
Psychology 33 16%
Nursing and Health Professions 14 7%
Pharmacology, Toxicology and Pharmaceutical Science 12 6%
Social Sciences 8 4%
Other 24 12%
Unknown 36 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2017.
All research outputs
#3,371,388
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#5,581
of 8,923 outputs
Outputs of similar age
#41,488
of 159,646 outputs
Outputs of similar age from Cochrane database of systematic reviews
#49
of 100 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 159,646 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 100 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.